What does PHARMACIE DES ARCHIDUCS do?

PHARMACIE DES ARCHIDUCS is a pharmacy in Watermaal-Bosvoorde. Private Limited, started on 24 July 2014, 1 establishment.

What is the address of PHARMACIE DES ARCHIDUCS?

The registered office of PHARMACIE DES ARCHIDUCS is located at Aartshertogenlaan 38, 1170 Watermaal-Bosvoorde.

Is PHARMACIE DES ARCHIDUCS still active?

Yes. According to the CBE (31 October 2026) PHARMACIE DES ARCHIDUCS is active, legal situation “Normale toestand”, started on 24 July 2014.

Is PHARMACIE DES ARCHIDUCS registered on Peppol?

Yes, PHARMACIE DES ARCHIDUCS is registered on the Peppol network with ID 0208:0556828795.

What is the enterprise number of PHARMACIE DES ARCHIDUCS?

The enterprise number of PHARMACIE DES ARCHIDUCS is BE0556828795.

When was PHARMACIE DES ARCHIDUCS founded?

PHARMACIE DES ARCHIDUCS was founded on 24 July 2014.

Who are the directors of PHARMACIE DES ARCHIDUCS?

According to the 2025 annual accounts, the directors of PHARMACIE DES ARCHIDUCS are: AGANJU HOLDING SRL.

Is PHARMACIE DES ARCHIDUCS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 July 2014; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE DES ARCHIDUCS make in 2025?

PHARMACIE DES ARCHIDUCS posted a profit after taxes of € 66 in financial year 2025.

What is the revenue of PHARMACIE DES ARCHIDUCS?

As a small company, PHARMACIE DES ARCHIDUCS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 97,965.

How much does an employee at PHARMACIE DES ARCHIDUCS earn?

The average wage cost per full-time employee at PHARMACIE DES ARCHIDUCS was € 66,800 in 2024: staff costs of € 66,830 for 1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

PHARMACIE DES ARCHIDUCS (Private Limited)

Dossier PHARMACIE DES ARCHIDUCS, printed on 31 October 2026 from databakkes.be/en/0556828795/pharmacie-des-archiducs. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 2 of the last 4 fiscal years.
Tight liquidity NBB

Cash and receivables cover 50 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMACIE DES ARCHIDUCS from Watermaal-Bosvoorde, company number BE0556828795, closed financial year 2025 with a result of € 66 after tax. For that financial year PHARMACIE DES ARCHIDUCS recorded a gross margin of € 97,965 and equity of € -31,584. Compared with financial year 2024, the result moved from € -55,554 to € 66. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Caution

€ -31,584

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 66

▲ still € 55,554 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 29,291

▲ 165% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -50,134.

People and assets in 2025

Wage cost

€ 77,884

▲ 17% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 106,831

▲ 61% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 39,734

▲ 195% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 67,407 Gross margin 2022: € 67,407 First fiscal year in the series	€ 43,807 Gross margin 2023: € 43,807 ▼ 35% vs 2022 (€ 67,407) Unfavourable step	€ 30,025 Gross margin 2024: € 30,025 ▼ 31% vs 2023 (€ 43,807) Unfavourable step	€ 97,965 Gross margin 2025: € 97,965 ▲ 226% vs 2024 (€ 30,025) Favourable step	▲ 226%
Profit after taxes	€ -12,533 Profit after taxes 2022: € -12,533 First fiscal year in the series	€ -39,609 Profit after taxes 2023: € -39,609 ▼ € 27,076 vs 2022 (€ -12,533) Unfavourable step	€ -55,554 Profit after taxes 2024: € -55,554 ▼ € 15,945 vs 2023 (€ -39,609) Unfavourable step	€ 66 Profit after taxes 2025: € 66 ▲ € 55,620 vs 2024 (€ -55,554) Favourable step	▲ € 55,620
Equity	€ 63,514 Equity 2022: € 63,514 First fiscal year in the series	€ 23,905 Equity 2023: € 23,905 ▼ 62% vs 2022 (€ 63,514) Unfavourable step	€ -31,650 Equity 2024: € -31,650 ▼ € 55,554 vs 2023 (€ 23,905) Unfavourable step	€ -31,584 Equity 2025: € -31,584 Unchanged (€ -31,650) Favourable step
Total debts	€ 237,845 Total debts 2022: € 237,845 First fiscal year in the series	€ 289,347 Total debts 2023: € 289,347 ▲ 22% vs 2022 (€ 237,845) Unfavourable step	€ 245,005 Total debts 2024: € 245,005 ▼ 15% vs 2023 (€ 289,347) Favourable step	€ 236,948 Total debts 2025: € 236,948 ▼ 3% vs 2024 (€ 245,005) Favourable step	▼ 3%
Cash	€ 34,380 Cash 2022: € 34,380 First fiscal year in the series	€ 35,203 Cash 2023: € 35,203 ▲ 2% vs 2022 (€ 34,380) Favourable step	€ 11,041 Cash 2024: € 11,041 ▼ 69% vs 2023 (€ 35,203) Unfavourable step	€ 29,291 Cash 2025: € 29,291 ▲ 165% vs 2024 (€ 11,041) Favourable step	▲ 165%
Retained profit	€ 44,964 Retained profit 2022: € 44,964 First fiscal year in the series	€ 5,355 Retained profit 2023: € 5,355 ▼ 88% vs 2022 (€ 44,964) Unfavourable step	€ -50,200 Retained profit 2024: € -50,200 ▼ € 55,554 vs 2023 (€ 5,355) Unfavourable step	€ -50,134 Retained profit 2025: € -50,134 Unchanged (€ -50,200) Favourable step
Bank debt	€ 61,124 Bank debt 2022: € 61,124 First fiscal year in the series	€ 36,153 Bank debt 2023: € 36,153 ▼ 41% vs 2022 (€ 61,124) Favourable step	€ 10,729 Bank debt 2024: € 10,729 ▼ 70% vs 2023 (€ 36,153) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 10,729) Favourable step	▼ 100%
Balance sheet total	€ 301,358 Balance sheet total 2022: € 301,358 First fiscal year in the series	€ 313,252 Balance sheet total 2023: € 313,252 ▲ 4% vs 2022 (€ 301,358) Unchanged	€ 213,355 Balance sheet total 2024: € 213,355 ▼ 32% vs 2023 (€ 313,252) Unchanged	€ 205,364 Balance sheet total 2025: € 205,364 ▼ 4% vs 2024 (€ 213,355) Unchanged	▼ 4%
Employees (FTE)	1 Employees (FTE) 2022: 1 First fiscal year in the series	1 Employees (FTE) 2023: 1 Unchanged (1) Unchanged	1 Employees (FTE) 2024: 1 Unchanged (1) Unchanged	-

Key figures of PHARMACIE DES ARCHIDUCS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE DES ARCHIDUCS?

What happened at PHARMACIE DES ARCHIDUCS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 66. filed late Source: NBB ↗
2018 AGANJU HOLDING SRL became a director. NBB
Jul 24, 2014 New establishment in Watermaal-Bosvoorde. KBO
Jul 24, 2014 Start of the company according to the CBE. KBO

In short

From € 12,533 loss in 2022 to € 66 profit in 2025.

Paid € 600 in corporate taxes since 2022.

Best year ever: 2025, with € 66 profit.

On average € 30,000 of value added per employee in 2024.

Original PDFs at the National Bank ↗

Management

AGANJU HOLDING 100%

The stake of AGANJU HOLDING comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMACIE DES ARCHIDUCS

Behind PHARMACIE DES ARCHIDUCS is AGANJU HOLDING SRL. The shares are held by AGANJU HOLDING (100%).

Directors

According to the 2025 annual accounts

AGANJU HOLDING SRL

Director · represented by HAMIAFO NGATCHI HERVE

Also active at: AGANJU CONCEPT, D5-PHARMA, D4-PHARMA, CENTRE MEDICAL DEWAND, PHARMACIE DU ROOSENDAEL

since 2018

Shareholders

AGANJU HOLDING

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Aartshertogenlaan 38

1170 Watermaal-Bosvoorde

2.233.216.350

Aartshertogenlaan 48

1170 Watermaal-Bosvoorde

Active since 24 July 2014

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Unité TVA AGANJU-ARCHIDUCS

Piggly Foundation

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0556.828.795
VAT number: BE 0556.828.795
Registered office: Aartshertogenlaan 38, 1170 Watermaal-Bosvoorde
Names & denominations: PHARMACIE DES ARCHIDUCS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 July 2014
Peppol: Active · Active since 11 Dec 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗